BridgeMD
New treatment option for Stress Disorders, Post-Traumatic
Official title Postpartum Care in the NICU (PeliCaN) Transitions
ClinicalTrials.gov ID: NCT06521398
What this study is testing
- What it's testing
- This is a randomized controlled trial of a dyad-centered, doula support and healthcare coordination model of care in a large urban neonatal intensive care unit (NICU), which serves a high-risk, low-income, majority Black population. In addition to doula support and coordination of care in the NICU, there will be a warm handoff to a community doula to continue the support once infants leave the Hospital of the University of Pennsylvania (HUP) NICU.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older, women only
You may be able to join if
- HUP postpartum patients who are at least 16 years old at the time their newborns' birth
- Infant born at HUP
- Preterm birth \<34 weeks
- English language speaking
You likely can't join if
- Unable to read or sign informed consent
- Parents of infants transferred into HUP NICU
- If the medical team believes that the infant may not live or be transferred to another hospital in upcoming weeks
- HUP postpartum patients who are less than 16 years of age at the time of their newborns' birth
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.